PATENT CLAIM ANALYSIS

Application Number: 16248912
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or disorders using the TNFα antisense oligonucleotides and related products are provided.

Claim (Index 80):
The method of  claim 79 , wherein the molecular species is selected from the group consisting of a spacer, a lipid, a sterol, cholesterol, stearyl, C16 alkyl chain, bile acids, cholic acid, taurocholic acid, deoxycholate, oleyl litocholic acid, oleoyl cholenic acid, glycolipids, phospholipids, sphingolipids, isoprenoids, such as steroids, vitamins, such as vitamin E, saturated fatty acids, unsaturated fatty acids, fatty acid esters, such as triglycerides, pyrenes, porphyrines, Texaphyrine, adamantane, acridines, biotin, coumarin, fluorescein, rhodamine, Texas-Red, digoxygenin, dimethoxytrityl, t-butyldimethylsilyl, t-butyldiphenylsilyl, cyanine dyes (e.g. Cy3 or Cy5), Hoechst 33258 dye, psoralen, and ibuprofen.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15517064', '10644052', '14114471', '11748422', '12952863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7907977029186126
- 35 USC 102 Novelty (BERT): 0.6106477912477721
- Combined Prediction Score: 0.7727827117515287
- Mean Citation Score: 328.277526
- Max Citation Score: 593.3532
- Similarity Product: 460.89829064075946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test